Vreeland, Timothy J.
Collings, Amelia T.
Ozair, Ahmad
Adams, Alexandra M.
Dirks, Rebecca
Kushner, Bradley S.
Sucandy, Iswanto
Morrell, David
Whiteside, Jake
Ansari, Mohammed T.
Cloyd, Jordan
Cleary, Sean P.
Ceppa, Eugene
Abou-Setta, Ahmed M.
Alseidi, Adnan
Awad, Ziad
Ayloo, Subhashini
Buell, Joseph
Orthopoulos, Georgios
Richardson, William
Sbayi, Samer
Wakabayashi, Go
Asbun, Horacio
Slater, Bethany J.
Pryor, Aurora D.
Jeyarajah, D. Rohan http://orcid.org/0000-0002-1673-678X
Article History
Received: 25 August 2022
Accepted: 16 January 2023
First Online: 21 February 2023
Compliance with ethical standards
:
: Dr. Vreeland receives financial support for travel expenses and registration fees for meetings from the Metis Foundation and consulting fees from Bantam Pharmaceuticals for clinical trial design. Dr. Collings was employed by SAGES as the guideline’s fellow. Dr. Adams receives financial support for travel expenses and registration fees for annual meetings for SAGES and AHPBA from the Metis Foundation. Dr. Dirks has privately purchased stock in Johnson & Johnson. Dr. Ansari is a consultant guideline methodologist and remunerated by SAGES for contribution to this work. Dr. Cleary receives consulting fees from Ethicon, Erbe, and Olympus. Dr. Buell receives speaker and consulting fees from Ethicon and Covidien. Dr. Slater receives consulting fees from Bolder Surgical and Cook Medical. Dr. Pryor receives speaker fees from Gore, Ethicon, and Stryker. Dr. Jeyarajah is a consultant for Ethicon, Angiodynamics, and Sirtex. Drs. Ozair, Kushner, Sucandy, Morrell, Cloyd, Ceppa, Abou-Setta, Alseidi, Awad, Ayloo, Orthopoulos, Richardson, Sbayi, Wakabayashi, and Mr. Whiteside have no conflicts of interest.